Biostem

Biostem

Created using Figma
Tecnologia de célula bioquímica altamente sofisticada combinada com a tecnologia blockchain.

Biostem é uma tecnologia de ponta que visa revolucionar a moderna indústria médica e de biotecnologia, fornecendo uma plataforma descentralizada que pode ser usada para atividades transacionais, fins de rastreamento, terceirização e fabricação por contrato, monitoramento e registro de dados de pacientes, agilização de ciclos de vida e cuidados médicos , manufatura por contrato e gerenciamento de ensaios clínicos. Ao fazer isso, também visamos garantir que os produtos Biotech modernos estejam prontamente disponíveis para todos - não apenas para os ricos - a preços mais baratos.
PRE SALE
1 de abr. de 2019
30 de mai. de 2019
100% completou
Fundos arrecadados - sem dados
past
Detalhes do token
Distribuição de Token
ICO Crowdfunding 30%
Founder Team 15%
Angel Funding 45%
Publisher 10%
Moedas Aceitas
ETH
Detalhes da Companhia
País registrado
Malaysia
detalhes adicionais
Categorias
Plataforma, tecnologia

Sobre Biostem

MYK was established as a biotechnology manufacturer and Biotech Research Laboratory aiming to contribute to the world health and medical industry through globalizing biotechnology. Its main business areas are: health and medical industry, finance and industrial investment, and sophisticated technologies such as blockchain and Biotechnology. MYK regards technology as the core and quality as its life, and wholeheartedly builds the company into a world-class branded enterprise. Comprised of a world-class medical team and cutting-edge biotechnology equipment, MYK provides a global scaled advanced medical technology and research service platform. It provides world-class screening, diagnosis, treatment and rehabilitation services for oncological diseases; has built patient-centered, unique health management system; provide community-based prevention, diagnosis, treatment, rehabilitation, and health services, while also providing medical services. In addition, anti-aging services are supplemented to create a brand-new living experience; in response to the needs of an aging population and the improvement of the quality of life of residents, the company has created the “MYK Cell Bank” as an important carrier for healthy living and provides high-end international medical care. Health management, health care services and other age-based health care services should provide strength for the common people to achieve physical and mental health and a better life.

Biostem is a project by MYK aiming to revolutionize the traditional Medical and Biotechnology industry by providing a decentralized blockchain for storing patient, clinical and research record, and smart contracts like features for trustless outsourcing of Biotech contracts.

Our Mission

Biostem aims to contribute to the world health and medical industry by creating an ecosystem that would make the Patient’s Clinical Record and the Biotech Contract Outsourcing process, distributed through a decentralized blockchain, so that, anyone can have access to high end, state of the art medical diagnosis, treatment and Biotech products at ease.

Biostem

Biostem is state of the art ERC-20 Virtual Currency that allows peer to peer mode of payment and is deployed on decentralized ethereum blockchain based technology. The currency would be used for funding the research work, daily transactional activities happening within the Biostem health and financial ecosystem, for health care services and can also be used as a peer to peer exchange and store of value between users: securely, efficiently at reduced costs. Biostem will utilize ethereum blockchain technology to enhance its services to patients, hospitals, research centers and daily consumers, sellers, and merchants. This allows a level of transparency that was previously unrealized, while incentivizing users to adopt and use the platform. This will be done through the creation and use of Biostems.

Biostem Equipe

Verificado 0%

Atenção. Existe o risco de os membros não verificados não serem realmente membros da equipe

Dr. Rubern
Chief Executive Officer
não verificado
Dawson Roland
Chief Technology Officer
não verificado
Kelson Beck
Chief Marketing Officer
não verificado
Matthew Hudson
Chief Financial Officer
não verificado
Catherine Harrison
Chief Operating Officer
não verificado
Rina
Biotech Consultant
não verificado
Allyson Brock
Human Resource Director
não verificado
Jozie Ayaz Khan
Business Development Director
não verificado
Brayden Parker
Biotech Research Consultant
não verificado
Sanjay Uttam Kharade
Business Consultant - Asia
não verificado

Biostem Últimas notícias

  • Como pode haver diferenças de horário nas atualizações de informações, informações precisas sobre cada projeto da OIC devem ser verificadas por meio de seu site oficial ou de outros canais de comunicação.
  • Esta informação não é uma sugestão ou conselho para investir no financiamento da OIC. Por favor, investigue completamente as informações relevantes e decida sobre a participação da OIC.
  • Se você acha que há problemas ou problemas a serem corrigidos neste conteúdo, ou se gostaria de enviar seu próprio projeto da OIC para ser listado, envie-nos um e-mail. um>
Leia o aviso e o aviso de risco. Mostrar aviso legal e aviso de risco.